Clinical impact of bacterial contamination of perfusion fluid in kidney transplantation

A Ranghino1, D Diena1, F Simonato1

  • 1Renal Transplantation Center "A. Vercellone", Division of Nephrology Dialysis and Transplantation, Department of Medical Sciences, Città della Salute e della Scienza Hospital and University of Torino, Corso Dogliotti 14, 10126 Turin, Italy.

Springerplus
|January 14, 2016
PubMed

Insights

Perfusion fluid contamination is common in kidney transplant recipients, but infections are rare. Preemptive therapy for bacterial contamination did not reduce infection rates, suggesting a potential for reduced antibiotic use.

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Clinical Microbiology

Background:

  • Perfusion fluid (PF) contamination poses a risk of serious infections in kidney transplant recipients.
  • Preemptive therapy (PE-T) is standard for yeast PF contamination, but its efficacy for bacterial contamination is uncertain.

Purpose of the Study:

  • To investigate the incidence of bacterial contamination in perfusion fluid (PF).
  • To evaluate the impact of preemptive therapy (PE-T) on clinical outcomes in kidney transplant recipients with bacterial PF contamination.

Main Methods:

  • Retrospective analysis of microbiological data from 290 perfusion fluids (PF) and clinical data from corresponding kidney transplant recipients (January 2010 - December 2012).
  • Recipients with bacterial PF contamination (n=101) were categorized into three groups: PE-T treated (resistant/sensitive to perioperative antibiotic prophylaxis - PAP) and PE-T untreated (resistant to PAP).

Main Results:

  • The incidence of positive PF was 34.8%, with staphylococci (50.4%) and Candida albicans (9.9%) being the most common contaminants.
  • No significant differences in PF-related infection rates were observed among the three treatment groups.

Conclusions:

  • Despite frequent PF contamination, the incidence of PF-related infections in kidney transplant recipients is low.
  • Preemptive therapy (PE-T) for bacterial PF contamination did not demonstrate a reduction in infection rates in this study.
  • Findings suggest a potential for reducing antibiotic therapy, pending confirmation from larger prospective trials. Close clinical and microbiological monitoring is recommended for recipients with PF contamination.

Related Concept Videos

Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
560
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
686
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
769
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
472
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.6K
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
455